About - Executive Team

Mike Hooven

President and CEO

> Read Biography

Mike has over 30 years of experience in the medical device industry in a broad variety of technical and clinical areas. He is the founder of five medical device companies and holds over 100 issued and pending US patents.

Mike is the founder, and a Director of AtriCure, Inc. (Nasdaq ATRC). AtriCure is a Medical Device company that manufactures and sells surgical devices to treat the most serious forms of atrial fibrillation. AtriCure has grown rapidly to become the market leader, with over 200,000 procedures performed. AtriCure completed a successful Initial Public Offering on August 5, 2005, and currently trades on the NASDAQ under the symbol ATRC. Mike also is a Director and past Chairman of BioOhio, a state-funded organization to accelerate life-science start-up companies in Ohio. Mike was recently appointed by the Governor to the Third Frontier Advisory Board, a $2.3BB state funded initiative to accelerate high tech job creation in Ohio. Mike also sits on the Commercial Advisory Committee for the University of Cincinnati.

Mike previously held positions as the Chairman and CEO of AtriCure, and the Founder and Chairman of Enable Medical, a surgical device manufacturer that was acquired by AtriCure in August of 2005. Mike founded Enable in April of 1994, and prior to that he headed up all internal product development at Ethicon Endo-Surgery from 1988 to 1994. Mike held Engineering positions at Siemens/Pacesetter from 1986 to 1988, and at Cordis Corporation from 1981 to 1986. He earned a BS in Physics and a Master of Science in Mechanical Engineering from the University of Michigan.

Tim Flaherty

Vice President and Chief Financial Officer

> Read Biography

Tim Flaherty was named Vice President and Chief Financial Officer of Enable Injections in February 2015. Tim brings 25 years of public and private company experience in finance, accounting, human resource, and information technology management. He is responsible for the finance, accounting, information technology, and will play a key role in business development and strategy of Enable Injections.

Prior to Enable Injections, Tim served as North American CFO for Bonfiglioli, Inc., a leading billion dollar global Italian owned company in the power transmission market. He played a key role in developing the finance, accounting, human resource, and information technology departments to allow the North American business units to scale from $68 million to $140 million in four years. Tim was nominated for CFO of the year in 2014 by the Cincinnati Business Courier in the large private company category for his achievements at Bonfiglioli, Inc.

Prior to Bonfiglioli, Tim held several executive financial roles in large publicly traded companies and small private companies. The companies that Tim worked for included ArvinMeritor (NYSE:ARM), Ametek (NYSE:AME), and AtriCure /Enable Medical (NASD: ATRC). Some of his responsibilities included: Merger and Acquisitions, IPO experience, plant consolidations, shared-service operations, multi-location oversight, SEC Reporting, system implementations, scalability, cost and risk controls, internal controls, Sox compliance, financial modeling, business development, strategy, budgeting, forecasting, due diligence, cash management and treasury, etc.

Tim earned his accounting degree from the University of Kentucky and his Master of Business Administration from Xavier University, Cincinnati, OH.

Tim and his wife, Karin, have been married 16 years and have two children.

Matthew J. Huddleston

Vice President of Research and Development

> Read Biography

Mr. Matthew J. Huddleston serves as Vice President, Product Development and Program Management for Enable Injections.  He is an experienced medical device professional with over 15 years’ experience in start-up environments with particular emphasis in project management, design, development, manufacturing, regulatory and intellectual property.  He has several issued and pending patents in the medical device field including soft tissue and cardiovascular fixation devices and delivery instruments, histologic automated embedding systems, laparoscopic visualization devices, and automatic injection devices.  He is a professional engineer and a licensed patent agent.  Mr. Huddleston holds a Bachelor of Science in Mechanical Engineering from Purdue University and a Master of Science in Biomedical Engineering from The Ohio State University.

Jeannie Joughin

Vice President, Corporate Development

> Read Biography

Jeannie Joughin has also held various scientific positions including Senior Research Scientist, Post-Doctorate and Senior Post-Doctorate positions in Australia at The Alfred Hospital, The Walter & Eliza Hall Institute, as well as internationally in Austria (University Clinic, Innsbruck) and Switzerland (Ludwig Institute for Cancer Research, Lausanne). Dr. Joughin began her career in the pharmaceutical industry in 1992 as a Clinical Research Manager with Bristol-Myers Squibb. After managing local trials in oncology and cardiology, she moved into New Product Commercialisation as the interface between the medical and marketing departments. From there, Dr. Joughin worked in Brand Management. After successfully completing several marketing roles in the National Stroke Foundation, MediMark International and Mayne Pharma, Dr. Joughin joined CSL Biotherapies in 2005 as Director, Pharmaceuticals Marketing and In-licensing. She assumed responsibility for a portfolio of pharmaceutical products from several licensing partners in various therapeutic areas. Her responsibilities included extending distribution agreements with current partners when appropriate and securing various new product distribution agreements. As Vice President, Business Development at CSL Behring Dr Joughin was responsible for managing business licensing arrangements and relationships. This involved close liaison with CSL Behring’s Commercial Development Team in the US, Germany and Switzerland. Now as Vice President, Corporate Development and member of the executive team, Jeannie Joughin is responsible for business development, strategic alliances, alliance management, marketing and clinical activities. Dr Joughin will be working cross-functionally to select and prioritize Enable’s global portfolio.

Eileen Rogers

Vice President of Operations

> Read Biography

Eileen has more than 25 years of experience in the life sciences industry. A majority of her career has focused on biopharmaceutical manufacturing of sterile products in compliance with the FDA’s Code of Federal Regulations as well as ISO and ICH guidelines to meet global regulatory needs. Eileen filled various management roles in Validation, Engineering and Capital Expansion while working for both Stryker Biotech and Amylin Pharmaceuticals. As the Senior Director of Operations at Amylin, Eileen led a cross functional team in the development and approval of an innovative drug delivery system for a sterile injectable product. Currently, Eileen is the Vice President of Operations at Enable Injections working on the design, development and eventual commercialization of another novel drug delivery system for large volume deliveries (> 3 mL). Eileen received her Bachelor of Science degree in Civil Engineering from Drexel University and a Masters degree in Engineering Management from the Thayer School of Engineering at Dartmouth College.

Susan Spies

Vice President of Administration

> Read Biography

Susan Spies, Vice President of Administration, has over 20 years of experience in start-up biotechnology and life sciences industries. Sue was one of the first employees of Enable Injections, and built the human resources, IT, investor relations and finance departments. She was also responsible for establishing the infrastructure of the human resources, finance, and IT departments at Enable Medical Corporation and AtriCure, Inc. Sue has played an integral part in each start-up company by supporting employee growth, managing the finances, and providing an excellent corporate culture. In earlier years, she worked as a senior IT analyst for Baxter and Cordis Corporation supporting their financial systems. Susan earned her B.S. in Accounting from the University of Delaware and an M.S. in Management Information Systems from the University of Miami.

Dominick C. Villani III

Vice President of Quality / Regulatory Affairs

> Read Biography

Dominick has been on staff with Enable Injections for approximately 1.5 years.  Prior to him starting his tenure with Enable Injections, he studied general Biological Sciences, with an emphasis in Microbiology, at the California Lutheran University in Thousand Oaks, California.  Following his education, he proceeded to build a successful professional career in the Biotechnology, Vaccine, Pharmaceuticals (Sterile and Non-Sterile), and Medical Device sectors.  For over 20 years, Mr. Villani has been responsible for defining, building, and managing requirements within Manufacturing, Quality Control, Quality Assurance, and Regulatory Affairs areas with multiple companies such as:  Amgen, Amylin, AstraZeneca, Bristol-Myers Squibb, and Bioport.  Mr. Villani has been a speaker with the Pharmaceutical Microbiology Forum (PMF) on topics such as Aseptic Processing and Gowning Requirements.  He is a member of the International Organization for Standardization (ISO) for needle-based injections systems and on-body delivery systems.

John F. Love

Vice President of Development and Manufacturing

> Read Biography

John F. Love, Vice President, Development and Manufacturing for Enable Injections Inc.

John has over 30 years of leadership, R&D, and Operations experience in the medical device industry that include the specialty product areas of peritoneal dialysis, mechanical stapling devices, coronary artery brachytherapy, drug eluting stents, endovascular aortic stent repair, and spinal implant systems. Prior to joining Enable, John was the Vice President of Operations at Triangle Manufacturing in New Jersey where he directed a 240-person medical device CNC contract manufacturing facility. From 2007-2016, John held the positions of Corporate Vice President of R&D and Operations, Corporate Vice President of R&D, Quality, Regulatory and Medical Scientific Affairs, and Vice President of Research and Development at Aesculap Implant Systems based in Pennsylvania. Prior to Aesculap, John was the Vice President of Engineering at The MedTech Group, a plastics injection molding company in New Jersey. John has also held leadership and management positions at the following companies: Datascope Intervascular, JFL & Associates, Cordis Corporation, Novoste Corporation, Ethicon Endo Surgery, and Baxter Laboratories. John holds a Bachelor of Science in Biomedical Engineering from the University of Illinois, Chicago and a Master of Engineering Management from Northwestern University.